Previous Article | Next Article 
Journal of Clinical Microbiology, September 1998, p. 2514-2521, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Antigenic Characterization of Hantaan and Seoul Virus
Nucleocapsid Proteins Expressed by Recombinant Baculovirus: Application
of a Truncated Protein, Lacking an Antigenic Region Common to the
Two Viruses, as a Serotyping Antigen
Mayuko
Morii,1
Kumiko
Yoshimatsu,1
Jiro
Arikawa,1,*
Guizen
Zhou,1,2
Hiroaki
Kariwa,3 and
Ikuo
Takashima3
Hokkaido University School of
Medicine1 and
Graduate School of
Veterinary Medicine,3 Hokkaido University,
Sapporo 060, Japan, and
Chinese Academy of Preventive Medicine,
Institute of Virology, Beijing, China2
Received 9 February 1998/Returned for modification 6 April
1998/Accepted 1 June 1998
 |
ABSTRACT |
Hantaan virus (HTN) and Seoul virus (SEO) are members of the genus
Hantavirus in the family Bunyaviridae and are
causative agents of hemorrhagic fever with renal syndrome. The complete and truncated nucleocapsid proteins (NP) of HTN and SEO were expressed by a recombinant baculovirus system. Antigenic characterization of the
NP using monoclonal antibodies (MAbs) indicated that the binding sites
for the serotype-specific MAbs were located between amino acids (aa)
155 and 429. A Western blot assay indicated that the serotype-specific
epitopes were conformation dependent. An indirect immunofluorescence
antibody (IFA) assay with the truncated NP (aa 155 to 429) was able to
distinguish convalescent-phase sera from HTN and SEO patients. However,
the antibody titers with the truncated NP were lower than those with
the whole NP. The truncated NP of SEO (aa 155 to 429) could be used as
an enzyme-linked immunosorbent assay (ELISA) antigen, but the truncated
NP from HTN lost its reactivity when used for ELISA. The IFA assay
using baculovirus-expressed truncated NP as an antigen is a rapid,
simple, and safe test for distinguishing between HTN and SEO infections by serotype.
 |
INTRODUCTION |
Hemorrhagic fever with renal
syndrome (HFRS) and hantavirus pulmonary syndrome (HPS) are
rodent-borne viral zoonoses caused by viruses in the genus
Hantavirus, family Bunyaviridae (3). At least 14 virus species and 10 serotypes have been identified by
genetic and antigenic characterizations, respectively. Each hantavirus
appears to have a single predominant natural reservoir (19).
Four of the hantavirus species, Hantaan (HTN), Seoul (SEO),
Dobrava/Belgrade, and Puumala (PUU), which are all different serotypes, are known to cause HFRS, while Sin Nombre virus causes HPS. In far
eastern Asia, at least two serotypes of hantavirus, HTN and SEO, are
spreading (19). Since the severity of infection depends on
the viral serotype, a specific diagnosis of the causative virus is
important, not only for rodent control but also for therapeutic purposes.
Currently, the plaque reduction neutralization test (PRNT) is the most
specific serodiagnostic procedure for differentiating between HTN and
SEO infections (4). However, PRNT takes more than 1 week to
perform and requires a containment laboratory for virus manipulation.
Therefore, a simple, safe, and rapid diagnostic method which is able to
distinguish HTN from SEO infection serologically is required.
Hantavirus nucleocapsid protein (NP) possesses immunodominant, linear,
cross-reactive epitopes in the first 100 amino acids of the N terminus
(5, 7, 26). In addition, serotype-specific epitopes have
also been detected by serotype-specific monoclonal antibodies (MAbs) in
NP (15, 18, 28). We used truncated NP (trNP) expressed by a
recombinant baculovirus and found that the HTN-specific antigenic site
of the NP occupied about half of the C terminus of the NP
(28).
In this study, we examined specific regions of the HTN and SEO
serotypes on the NP in more detail and use specific regions to produce
a diagnostic antigen for serotyping.
 |
MATERIALS AND METHODS |
Viruses and cells.
HTN virus strain 76-118 (14),
SEO virus strain SR-11 (12), and PUU virus strain Sotkamo
(2) were used as representative strains of the HTN, SEO, and
PUU virus serotypes. They were propagated in the E6 clone of Vero cells
(ATCC c11008, CRL 1586) grown in Eagle's minimal essential medium
(Nissui, Tokyo, Japan) supplemented with 5% fetal bovine serum.
Recombinant baculoviruses (Autographa californica nuclear
polyhedrosis virus) containing coding information from the NPs of HTN
and SEO viruses were supplied by C. S. Schmaljohn of the U.S. Army
Medical Research Institute for Infectious Diseases (USAMRIID),
Frederick, Md. (21). Recombinant baculovirus containing coding information from the NP of PUU virus was supplied by A. Vaheri
of Helsinki University, Helsinki, Finland (24). The
recombinant baculoviruses were propagated in High Five cells grown in
Grace's insect cell culture medium (GIBCO BRL) supplemented with 10%
fetal bovine serum.
Construction of truncated recombinant baculoviruses.
Primers
were designed from previously published sequences (1, 20).
The portion of the gene coding for amino acids (aa) 155 to 429 of HTN
NP was amplified from cDNA of the S segment of HTN virus strain 76-118 (a gift from C. S. Schmaljohn) (20) with the primers
ATGCGGATTCGATTTAAGGATGA and
TTAGAGTTTCAAAGGCTCTTGGT. The first methionine codon (ATG,
underlined) was added as an initiation codon. The same region of SEO NP
was amplified from cDNA of the S segment of SEO virus strain SR-11 (a
gift from C. S. Schmaljohn) (1) with primers
ATGAGGATCAGATTCAAGGA and TTATAATTTCATAGGTTCCTGGT. The DNA was amplified in 30 cycles of 97°C for 30 s,
55°C for 30 s, and 72°C for 1 min. Then PCR products were
subcloned into pCRII plasmid (TA-cloning kit; Invitrogen) according to
the manufacturer's instructions. The cDNA encoding aa 155 to 429 was
excised from the pCRII plasmid by digestion with EcoRI
(Takara, Tokyo, Japan) and ligated into the donor plasmid pFASTBAC1
(GIBCO BRL). The cDNAs encoding aa 155 to 288 of HTN NP and aa 155 to
295 of SEO NP were generated by digestion of plasmid pFASTBAC1 which
contained aa 155 to 429 of HTN NP or SEO NP. Truncated genes encoding
aa 1 to 103, 1 to 244, and 1 to 355 of HTN NP were generated from cDNA
encoding the whole NP as described previously (28) and ligated into the donor plasmid pFASTBAC1. Five kinds of trNP from HTN
and two kinds of trNP from SEO were expressed by using the BAC-TO-BAC
baculovirus expression system according to the manufacturer's instructions (GIBCO BRL). The prepared recombinant baculoviruses were
stored for use as seed viruses at 4°C.
Preparation of recombinant NP (rNP) and trNP.
Monolayers of
High Five cells cultured in 75-cm2 flasks were inoculated
with 1 ml of recombinant baculovirus culture fluid (2.2 × 108 focus-forming units/ml). Six days later, the cells were
pelleted by low-speed centrifugation (1,400 × g for 5 min). The cells were resuspended in Dulbecco's phosphate-buffered
saline, pH 7.2 (PBS), and centrifuged again. Then the cells were
suspended in 2 ml of PBS and sonicated four times for 15 s on ice.
Proteinase inhibitors, EDTA (0.5 mg/ml), leupeptin (10 µg/ml),
pepstatin A (10 µg/ml), aprotinin (1 µg/ml), and
phenylmethylsulfonyl fluoride (1 µg/ml) were added to the extracts to
prevent the degradation of the antigens, and the cell extracts were
stored at
40°C.
The recombinant HTN NP and trNP (aa 1-103) were expressed as
biotinylated proteins in Escherichia coli by using the
PinPoint Xa vector (Promega) as previously described (28).
MAbs, immune sera, and patient sera.
MAb clones ECO2, ECO1,
and BDO1, directed against the NP of hantavirus, were supplied by
J. B. McCormick and C. J. Peters of the Centers for Disease
Control and Prevention, Atlanta, Ga. (18). We prepared clone
DCO3, directed against the NP of SEO virus. Clones E5/G6, C16D11,
F23A1, and C24B4, directed against the NP of HTN virus, were prepared
previously (28). Immune mouse serum was obtained from
Slc/ICR mice infected with HTN virus by intraperitoneal inoculation of
live virus (27). Immune rat serum was prepared by
intraperitoneal inoculation of live viruses into Slc/Wistar rats
(29). A total of 35 HFRS patient sera were provided by Y.-X.
Yu of the National Institute for the Control of Pharmaceutical and
Biological Products, Beijung, China. Thirty of these patients were
believed to be infected with HTN virus, and the others were thought to
be infected with SEO virus. Sera that were positive for SEO virus were
kindly provided by Y. Nishimune of the Research Institute for Microbial
Diseases, Osaka University (four serum specimens), and I. Kim of Seoul
National University, Seoul, Korea (six serum specimens). These sera
were thought to be infected with SEO type hantavirus during a
laboratory rat-associated infection. One serum specimen from a
nephropathia epidemica patient was provided by B. Niklasson of the
Swedish Institute for Infectious Disease Control.
Focus reduction NT.
The neutralization test (NT) was
performed essentially as described by Tanishita et al. (23)
with some modifications. In this study, the residual virus infectivity
was determined by indirect immunofluorescence staining, described
below. The NT titer was expressed as the reciprocal of the highest
serum dilution resulting in a reduction greater than 80% in the number
of infected cell foci.
IFA assay.
An indirect immunofluorescence antibody (IFA)
test was carried out by previously described methods (27).
Acetone-fixed smears of Vero E6 cells infected with hantaviruses or of
High Five cells infected with recombinant baculoviruses were used as
antigens. Fluorescein isothiocyanate-conjugated anti-human
immunoglobulin (heavy and light chains) goat immunoglobulin G (IgG)
(Cappel Laboratories, Cochranville, Pa.) was used as the second
antibody. IFA titers were expressed as the reciprocal of the highest
serum dilution that caused characteristic fluorescence in the
cytoplasm.
Western blotting.
Western blotting was performed according
to published methods (29). The denatured rNP or trNP antigen
from infected High Five cells (3.0 × 103 cells/lane)
was separated by sodium dodecyl sulfate-12% polyacrylamide gel
electrophoresis (13). Mouse or rat immune sera to
hantaviruses or a MAb to the NP (E5/G6) was used to detect antigen on
the membrane. Binding antibodies were detected with horseradish
peroxidase-labeled goat anti-rat IgG or horseradish peroxidase-labeled
goat anti-mouse immunoglobulins (Zymed, South San Francisco, Calif.).
4-Chloro-1-naphthol (Sigma Chemical Co., St. Louis, Mo.) was used as
the peroxidase substrate.
Capture ELISA.
Microtiter plates were coated with MAb E5/G6
(5 µg/ml in PBS) overnight at 4°C as the capture antibody. The
enzyme-linked immunosorbent assay (ELISA) was performed as described
previously (28). rNP expressed in E. coli by the
PinPoint Xa vector, which carries biotin as a tag, was used for an
avidin capture ELISA. We used essentially the same procedure described
previously (28).
 |
RESULTS |
Antigenic characterization of HTN and SEO NPs with MAbs.
As
shown in Table 1, HTN trNP which
expressed aa 1 to 103 (trNP HTN 1-103) reacted with three
cross-reactive clones (ECO2, ECO1, and GBO4). From the reactivity of
clone E5/G6 to trNP HTN 1-244, 155-288, and 155-429, the binding region
for clone E5/G6 should be located between aa 155 and 244. This agrees
with our previous result, in which a synthetic peptide comprising aa
166 to 175 bound to E5/G6 (28). Clones C16D11 and F23A1
reacted with trNP HTN 1-335 but not with trNP HTN 1-244, indicating
that the binding region for the two clones is located between aa 244 and 335. However, trNP HTN 155-429 and 155-288 lacked reactivity with
these two clones. This difference probably results from the conformational dependency of the epitopes in the N-terminal region of
NP. Nevertheless, trNP HTN 155-429 still reacted with HTN-specific clones (C24B4 and BDO1) but not with any cross-reactive clones except
E5/G6. Therefore, trNP HTN 155-429 was used as a serotyping antigen.
Since this antigen retains reactivity to E5/G6, this antibody was used
as the capture antibody for the ELISA. trNP SEO 155-429 also retained
reactivity with E5/G6 and a SEO-specific MAb (DCO3) and was used as a
SEO-specific diagnostic antigen.
Reactivity of trNP in Western blotting.
Expression of the
entire NP, and of trNP HTN 155-429 and trNP SEO 155-429 by a
baculovirus system, was confirmed by Western blot analysis. In the
Western blots, the complete NP and the trNPs reacted with E5/G6,
because MAb E5/G6 bound to the linear epitope at aa 166 to 175 (28) (Fig. 1a). The molecular
sizes of the whole and truncated products were 50 and 35 kDa,
respectively. The observed and expected sizes were the same. Although
mouse and rat immune sera to HTN or SEO strongly cross-reacted with the
whole rNPs of both HTN and SEO, the immune sera did not react with trNP
HTN 155-429 or trNP SEO 155-429 (Fig. 1b and c, lanes 3 and 4). These
results indicate that the truncated antigens lack the linear epitopes
that react with antibodies produced after a natural infection. The sera
from several HTN and SEO patients also gave the same pattern as these
experimentally infected animal sera (data not shown). Since the
baculovirus-expressed recombinant protein is highly sensitive to
cellular protease (27), the additional protein bands in Fig.
1, lanes 1 and 2 (all panels), and the doublet bands in 35-kDa trNPs
with MAb E5/G6 (Fig. 1a, lanes 3 and 4) were considered to be NP
fragments after degradation.

View larger version (42K):
[in this window]
[in a new window]
|
FIG. 1.
Detection of rNP and trNP with Western blots stained
with MAb E5/G6 (a), mouse sera infected with HTN virus (b), or rat sera
infected with SEO virus (c). Lane 1, HTN rNP (whole); lane 2, SEO rNP
(whole); lane 3, trNP HTN 155-429; lane 4, trNP SEO 155-429; lane 5, uninfected High Five cells. In each lane, 3.0 × 103
cells were applied.
|
|
IFA profiles of patient sera.
The IFA profiles of patient sera
with High Five cells expressing whole HTN or SEO rNP, trNP HTN 155-429, trNP SEO 155-429, or unrelated antigen are shown in Fig.
2. The whole NP showed strong
cross-reactivity with heterologous patient sera, while both the HTN and
SEO trNP antigens showed significantly higher reactivity with patient
sera infected with the homologous virus rather than the heterologous
virus. However, the intensity of fluorescence was weaker than with the
whole antigen.

View larger version (68K):
[in this window]
[in a new window]
|
FIG. 2.
IFA profiles of patient sera with High Five cells
expressing whole or truncated HTN or SEO rNP. Panels were stained with
HTN (a through e) or SEO (f through j) patient serum. High Five cells
expressed whole HTN rNP (a and f), whole SEO rNP (b and g), trNP HTN
155-429 (c and h), trNP SEO 155-429 (d and i), or recombinant p40 of
Borna disease virus (16) (e and j).
|
|
Reactivity of rNPs by IFA assay and ELISA.
To examine the
usefulness of the truncated antigens for serotyping, the reactivities
of patient sera to the truncated antigens were compared to the
reactivities with whole NPs and authentic viral antigens by IFA and
ELISA (Table 2). In the NT, patient sera
showed significantly higher titers of antibody to the homologous virus.
In the IFA assay, the HTN and SEO whole-NP antigens cross-reacted equally with HTN and SEO patient sera but to a lesser extent with PUU
patient sera. These cross-reactive patterns were the same as those
obtained with Vero cells infected with authentic viruses. trNP SEO
155-429 was able to distinguish SEO patient serum from HTN and PUU
patient sera. Particularly, HTN patient serum showed IFA titers of <32
to trNP SEO 155-429, even though its homologous antibody titer was very
high (16,384 to 32,768). On the other hand, trNP HTN 155-429 also
reacted only with HTN patient serum, but the antibody titers were more
than 1/100 lower than those with whole rNP. In the ELISA, patient sera
showed the same cross-reactivity as was seen with the IFA test (Table
2). Serial dilutions of the sera of standard patients, results for
which are shown in Table 2, were also examined (Fig.
3). Whole HTN and SEO rNP reacted with
both HTN and SEO patient sera, with similar intensities, in a
dilution-dependent manner (Fig. 3a and b). On the other hand, trNP SEO
155-429 reacted only with SEO patient sera (Fig. 3d), while trNP HTN
155-429 did not react with any sera (Fig. 3c). Thus, trNP SEO 155-429 was able to distinguish SEO infection from HTN infection serologically.

View larger version (39K):
[in this window]
[in a new window]
|
FIG. 3.
Serial dilutions of the sera of standard patients in the
ELISA. Optical densities at 490 to 600 nm
(OD490-OD600) are given for sera of patients
infected with HTN ( ) or SEO ( ) and for negative human sera (+ and
×). High Five cells expressed the NPs shown above the panels.
|
|
Serologic diagnoses of patient sera by IFA assay.
The trNP HTN
155-429 and trNP SEO 155-429 antigens were used to serotype groups of
patient sera, 20 HTN virus patient sera from China and 10 SEO virus
patient sera from Korea and Japan, in an IFA assay. Sera from China
seemed to be obtained from patients infected with HTN virus, based on
epidemiological data. In a prior study, an NT confirmed that the Korean
and Japanese patients were infected with SEO virus by laboratory rats.
The sera were screened at a single serum dilution (1:32). All the
patient sera were positive for either whole HTN or whole SEO antigens.
With the truncated antigens, the sera from all but one Chinese patient
were positive with trNP HTN 155-429 (19 of 20), and all were negative
with trNP SEO 155-429. Similarly, trNP SEO 155-429 reacted only with
the Korean and Japanese sera (10 of 10). These results show that both truncated antigens can be used as diagnostic antigens for serotyping in
an IFA assay.
Reactivities of patients' serial sera.
An IFA assay with rNP
was used to evaluate the reactivities of serial sera from Chinese
patients. Patients from Anhui and Henan provinces were infected with
HTN and SEO viruses, respectively (Table
3). All the sera from Anhui patients
(Table 3) showed significant IFA titers to Vero cells infected with
authentic virus, even in the febrile phase (acute phase), and reached
high titers by the recovery phase. Interestingly, acute-phase sera
showed relatively similar titers of antibody to the antigen in the Vero cells infected with authentic virus and the trNP HTN 155-429 antigen (1/2 to 1/8 IFA titer difference). However, in the recovery-phase sera,
the IFA titers to the truncated antigen were markedly lower than those
to the Vero cell antigen (1/64 to 1/256). Serial sera from Henan (Table
3), which were from SEO virus-infected patients, showed an apparent
increase in the antibody titers with the time since the onset of the
disease, although clinical records of the patients' symptoms were not
available. These patients were diagnosed as having SEO virus infection
by IFA with trNP SEO 155-429 and trNP HTN 155-429. In ELISAs using
recombinant baculovirus expressing NP antigens, the whole-NP antigens
cross-reacted strongly with heterologous sera (Fig.
4A). trNP SEO 155-429 was able to
distinguish SEO virus infection from HTN virus infection. However, trNP
HTN 155-429 showed only negligible reactivity, even with recovery phase
sera (Fig. 4B). An ELISA was also performed with E. coli-expressed antigens. Whole NP of HTN virus (aa 1 to 429) and
trNP HTN 1-103, expressed by an E. coli vector
(28), were used as antigens. The reactivity with trNP HTN
1-103 antigen was similar to that obtained with whole-NP antigen (Fig.
4C).

View larger version (14K):
[in this window]
[in a new window]
|
FIG. 4.
Reactivities of serial patients' sera in ELISA.
OD490-OD600 were plotted for acute-phase ( )
and convalescent-phase ( ) sera of patients from Anhui province and
for acute-phase ( ) and convalescent-phase ( ) sera of patients
from Henan province. Comparisons of ELISA ODs were made between whole
HTN rNP and whole SEO rNP (A), between trNP HTN 155-429 and trNP SEO
155-429 (B), and between whole HTN rNP and trNP HTN 1-103.
|
|
 |
DISCUSSION |
A baculovirus expressing trNPs of the HTN and SEO viruses, which
lacked the major linear epitope located in the first third of the
N-terminal part of the NP, was successfully used as a diagnostic antigen. An IFA assay and an ELISA using the truncated antigen expressed by the baculovirus were able to distinguish HTN and SEO virus
infections serologically.
The application of E. coli-expressed trNP as a serotyping
antigen was reported by Wang et al. (25). They used dot
matrix comparisons of the amino acid sequences of HTN, SEO, and PUU NPs to select two unique regions. These two regions were combined and
expressed by an E. coli vector. In this report, we
identified a particular region from the reactivity with
serotype-specific MAbs that was useful as a serotyping antigen. It has
been reported that the first 100 amino acids of the N terminus of the
NP in various hantaviruses contain several major linear epitopes
(5, 7, 26). The antigenicity of this region is highly
cross-reactive between HTN and SEO viruses. It is difficult to
differentiate between HTN and SEO virus infections by measuring the
titers of antibody against NP because the region is immunodominant
(9, 22). However, the production of serotype-specific MAb to
NP indicated the existence of a serotype-specific epitope on the NP. We
determined that a trNP that lacked 154 amino acids from the N terminus
of the NP retained reactivity to the serotype-specific antibody (Table
1). However, the reactivity of the serotype-specific antibody to
baculovirus-expressed antigen was much stronger than that to E. coli-expressed NP (28). Therefore, we tried to use the
trNP expressed by baculovirus for serotyping antigen. The different
characteristics of NP antigen expressed by baculovirus and E. coli were reported for PUU virus NP. The PUU NP expressed by
E. coli as a
-galactosidase fusion protein lacked
reactivity with the MAb that recognized the variable region of the NP
(aa 251 to 260), but baculovirus-expressed NP retained this reactivity. The method of antigen preparation, differences in the way the bacterial
product is folded, or fusion of a part of the protein that affects its
structure are all possible reasons for this difference (22).
In our experiment, trNP lacked reactivity with immune animal sera (Fig.
1) and patient sera (data not shown) by Western blot analysis,
indicating that the serotype-specific epitopes on the NPs of HTN and
SEO viruses were conformation dependent. As shown in Table 1, trNP HTN
155-288, which lacked a possible RNA-binding region (6),
also lacked reactivity with serotype-specific MAbs. This result
indicates that binding with the serotype-specific MAbs requires the
C-terminal region of NP. Since the amino acid sequences of the C
termini (RNA-binding regions) of HTN and SEO viruses are almost
identical, the antigenicities of these regions should also be
identical. Therefore, we propose that this region does not contain
strain-specific epitopes. Rather, it is important for maintaining the
structure of the NP as a whole.
The IFA assays with baculovirus-expressed trNP HTN 155-429 and trNP SEO
155-429 were able to differentiate the infections serologically with
the same sensitivity as the NT. However, the IFA titers with the
truncated antigens were lower than those with the native viral antigens
(Table 3) or whole NP (data not shown). This trend was more noticeable
in titrations of sera from HTN-infected patients (Table 3). With
acute-phase sera, there was less than an eightfold difference in IFA
titers between native and truncated antigens. In contrast, the
difference with convalescent-phase sera was around 128-fold. The IFA
titers against trNP 155-429 in the convalescent phase were relatively
lower than those in the acute phase. Hedman et al. conducted IgG
avidity assays and reported that high-avidity antibodies were produced
in the convalescent phase of hantavirus infection (8).
Therefore, the relative decrease of IFA titers to trNP 155-429 in
convalescent-phase sera might be reflected by the increase in
high-avidity antibodies against the N-terminal immunodominant and
cross-reactive region.
Without further purification, the trNPs were also used as ELISA
antigens with MAb E5/G6 as the capture antibody. Only trNP SEO 155-429 was able to differentiate SEO patient sera from HTN patient sera by
ELISA. trNP HTN 155-429 seemed to lose its reactivity, even with sera
from patients infected with HTN virus. Since this antigen retained its
reactivity in the IFA assay, the procedure used for antigen
preparation, perhaps sonication, may decrease the reactivity of its
serotype-specific epitope. This has been reported for PUU rNP in a
baculovirus vector (24). Additional studies of the use of
milder conditions for the solubilization procedure are needed. The
level of reactivity in an ELISA using the truncated antigen expressed
by E. coli (aa 1 to 103) was similar to that with whole NP
(aa 1 to 429), and both antigens were highly cross-reactive between HTN
and SEO patient sera. These results confirmed that the 100 N-terminal
amino acids of NP are a useful antigen for serological diagnoses.
Hantaviruses that are closely related to PUU virus antigenically and
genetically have been reported in Asia and the Far East. These include
Japanese PUU virus (11), Khbarovsk virus (10), and Lemmings virus (17). Epidemiological reports suggest
that it is necessary to monitor for PUU virus infection even in areas where PUU infection has not been reported previously. Since the antigenicity of PUU virus is considerably different from that of HTN
and SEO viruses, a combination of at least two different antigens,
either HTN and PUU or SEO and PUU, is necessary for this serological
surveillance.
 |
ACKNOWLEDGMENTS |
We thank Y. Nishimune of the Research Institute for Microbial
Diseases, Osaka University, B. Niklasson of the Swedish Institute for
Infectious Disease Control, Y.-X. Yu of the National Institute for the
Control of Pharmaceutical and Biological Products of China, I. Kim of
Seoul National University, and J. B. McCormick and C. J. Peters of the Centers for Disease Control and Prevention for providing
patient sera and MAbs. We also thank C. S. Schmaljohn of USAMRIID
and A. Vaheri of Helsinki University for supplying recombinant
baculoviruses and cDNAs of hantaviruses.
This study was partially supported by a grant-in-aid from the Ministry
of Education, Science, Culture, and Sports of Japan.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Institute for
Animal Experimentation, Hokkaido University School of Medicine,
Kita-15, Nishi-7, Kita-ku, Sapporo, 060, Japan. Phone: 81-11-706-6905. Fax: 81-11-706-7879. E-mail:
j_arika{at}med.hokudai.ac.jp.
 |
REFERENCES |
| 1.
|
Arikawa, J.,
H. F. Lapenotiere,
C. L. Iacono,
M. L. Wang, and C. S. Schmaljohn.
1990.
Coding properties of the S and the M genome segments of Sapporo rat virus: comparison to other causative agents of hemorrhagic fever with renal syndrome.
Virology
176:114-125[Medline].
|
| 2.
|
Brummer-Korvenkontio, M.,
H. Henittonen, and A. Vaheri.
1982.
Hemorrhagic fever with renal syndrome in Finland.
Scand. J. Infect. Dis.
38:88-91.
|
| 3.
|
Calisher, C. H.
1991.
Bunyaviridae, p. 273-283.
In
R. I. B. Francki, C. M. Fauquet, D. L. Knudson, and F. Brown (ed.), Classification and nomenclature of viruses. Fifth report of the International Committee on Taxonomy of Viruses. Springer Verlag, New York, N.Y.
|
| 4.
|
Chu, Y. K.,
C. Rossi,
J. W. Leduc,
H. W. Lee,
C. S. Schmaljohn, and J. M. Dalrymple.
1994.
Serological relationships among viruses in the Hantavirus genus, family Bunyaviridae.
Virology
198:196-204[Medline].
|
| 5.
|
Elgh, F.,
A. Lundkvist,
O. A. Alexeyev,
G. Wadell, and P. Juto.
1996.
A major antigenic domain for the human humoral response to Puumala virus nucleocapsid protein is located at the amino-terminus.
J. Virol. Methods
59:161-172[Medline].
|
| 6.
|
Gött, P.,
R. Stohwasser,
P. Schnitzler,
G. Darai, and E. K. Bautz.
1993.
RNA binding of recombinant nucleocapsid proteins of hantaviruses.
Virology
194:332-337[Medline].
|
| 7.
|
Gött, P.,
L. Zöller,
G. Darai, and E. K. F. Bautz.
1997.
A major antigenic domain of hantaviruses is located on the aminoproximal site of the viral nucleocapsid protein.
Virus Genes
14:31-40[Medline].
|
| 8.
|
Hedman, K.,
A. Vaheri, and K. M. Brummer.
1991.
Rapid diagnosis of hantavirus disease with an IgG-avidity assay.
Lancet
338:1353-1356[Medline].
|
| 9.
|
Hjelle, B.,
S. Jenison,
N. Torrez-Martinez,
B. Herring,
S. Quan,
A. Polito,
S. Pichuantes,
T. Yamada,
C. Morris,
F. Elgh,
H. W. Lee,
H. Artsob, and R. Dinello.
1997.
Rapid and specific detection of Sin Nombre virus antibodies in patients with hantavirus pulmonary syndrome by a strip immunoblot assay suitable for field diagnosis.
J. Clin. Microbiol.
35:600-608[Abstract].
|
| 10.
|
Hörling, J.,
V. Chizhikov,
Å. Lundkvist,
M. Jonsson,
L. Ivanov,
A. Dekonenko,
B. Niklasson,
T. Dzagurova,
C. J. Peters,
E. Tkachenko, and S. Nichol.
1996.
Khabarovsk virus: a phylogenetically and serologically distinct hantavirus isolated from Microtus fortis trapped in far-east Russia.
J. Gen. Virol.
77:687-694[Abstract/Free Full Text].
|
| 11.
|
Kariwa, H.,
S. Yoshizumi,
J. Arikawa,
K. Yoshimatsu,
K. Takahashi,
I. Takashima, and N. Hashimoto.
1995.
Evidence for the existence of Puumala-related virus Clethrionomys rufocanus in Hokkaido, Japan.
Am. J. Trop. Med. Hyg.
53:222-227.
|
| 12.
|
Kitamura, T.,
C. Morita,
T. Komatsu,
K. Sugiyama,
J. Arikawa,
S. Shiga,
H. Takeda,
Y. Akao,
K. Imaizumi,
A. Oya,
N. Hashimoto, and S. Urasawa.
1983.
Isolation of virus causing hemorrhagic fever with renal syndrome (HFRS) through a cell culture system.
Jpn. J. Med. Sci. Biol.
36:17-25[Medline].
|
| 13.
|
Laemmli, U. K.
1970.
Cleavage of structural proteins during assenbly of the head of bacteriophage T4.
Nature
227:680-685[Medline].
|
| 14.
|
Lee, H. W.,
P. W. Lee, and K. M. Johnson.
1978.
Isolation of the etiologic agent of Korean hemorrhagic fever.
J. Infect. Dis.
137:298-302[Medline].
|
| 15.
|
Lundkvist, A., and B. Niklasson.
1992.
Bank vole monoclonal antibodies against Puumala virus envelope glycoproteins: identification of epitopes involved in neutralization.
Arch. Virol.
126:93-105[Medline].
|
| 16.
|
Ogino, M.,
K. Yoshimatsu,
K. Tsujimura,
T. Mizutani,
J. Arikawa, and I. Takashima.
1998.
Evaluation of serological diagnosis of Borna disease infection using recombinant proteins in experimentally infected rats.
J. Vet. Med. Sci.
60:531-534[Medline].
|
| 17.
|
Plyusnin, A.,
O. Vapalahti,
Å. Lundkvist,
H. Henttonen, and A. Vaheri.
1996.
Newly recognised hantavirus in Siberian lemmings.
Lancet
347:1835[Medline].
|
| 18.
|
Ruo, S. L.,
A. Sanchez,
L. H. Elliott,
L. S. Brammer,
J. B. McCormick, and H.-S. Fisher.
1991.
Monoclonal antibodies to three strains of hantaviruses: Hantaan, R22, and Puumala.
Arch. Virol.
119:1-11[Medline].
|
| 19.
|
Schmaljohn, C., and B. Hjelle.
1997.
Hantaviruses a global disease problem.
Emerg. Infect. Dis.
3:95-104[Medline].
|
| 20.
|
Schmaljohn, C. S.,
G. B. Jennings,
J. Hay, and J. M. Dalrymple.
1986.
Coding strategy of the S genome segment of Hantaan virus.
Virology
155:633-643[Medline].
|
| 21.
|
Schmaljohn, C. S.,
K. Sugiyama,
A. L. Schmaljohn, and D. H. Bishop.
1988.
Baculovirus expression of the small genome segment of Hantaan virus and potential use of the expressed nucleocapsid protein as a diagnostic antigen.
J. Gen. Virol.
69:777-786[Abstract/Free Full Text].
|
| 22.
|
Sjölander, K. B.,
F. Elgh,
H. Kallio-Kokko,
O. Vapalahti,
M. Hägglund,
V. Palmcrantz,
P. Juto,
A. Vaheri,
B. Niklasson, and A. Lundkvist.
1997.
Evaluation of serological methods for diagnosis of Puumala hantavirus infection (nephropathia epidemica).
J. Clin. Microbiol.
35:3264-3268[Abstract].
|
| 23.
|
Tanishita, O.,
Y. Takahashi,
K. Yamanishi, and M. Takahashi.
1984.
Evaluation of focus reduction neutralization test with peroxidase-antiperoxidase staining technique for hemorrhagic fever with renal syndrome virus.
J. Clin. Microbiol.
20:1213-1215[Abstract/Free Full Text].
|
| 24.
|
Vapalahti, O.,
Å. Lundkvist,
H. Kallio-Kokko,
K. Paukku,
I. Julkunen,
H. Lankinen, and A. Vaheri.
1996.
Antigenic properties and diagnostic potential of Puumala virus nucleocapsid protein expressed in insect cells.
J. Clin. Microbiol.
34:119-125[Abstract].
|
| 25.
|
Wang, M.,
C. Rossi, and C. S. Schmaljohn.
1993.
Expression of non-conserved regions of the S genome segments of three hantaviruses: evaluation of the expressed polypeptides for diagnosis of haemorrhagic fever with renal syndrome.
J. Gen. Virol.
74:1115-1124[Abstract/Free Full Text].
|
| 26.
|
Yamada, T.,
B. Hjelle,
R. Lanzi,
C. Morris,
B. Anderson, and S. Jenison.
1995.
Antibody responses to Four Corners hantavirus infections in the deer mouse (Peromyscus maniculatus): identification of an immunodominant region of the viral nucleocapsid protein.
J. Virol.
69:1939-1943[Abstract].
|
| 27.
|
Yoshimatsu, K.,
J. Arikawa, and H. Kariwa.
1993.
Application of a recombinant baculovirus expressing hantavirus nucleocapsid protein as a diagnostic antigen in IFA test: cross reactivities among 3 serotypes of hantavirus which cause hemorrhagic fever with renal syndrome (HFRS).
J. Vet. Med. Sci.
55:1047-1050[Medline].
|
| 28.
|
Yoshimatsu, K.,
J. Arikawa,
M. Tamura,
R. Yoshida,
Å. Lundkvist,
B. Niklasson,
H. Kariwa, and I. Azuma.
1996.
Characterization of the nucleocapsid protein of Hantaan virus strain 76-118 using monoclonal antibodies.
J. Gen. Virol.
77:695-704[Abstract/Free Full Text].
|
| 29.
|
Yoshimatsu, K.,
J. Arikawa,
R. Yoshida,
H. Li,
Y. C. Yoo,
H. Kariwa,
N. Hashimoto,
M. Kakinuma,
T. Nobunaga, and I. Azuma.
1995.
Production of recombinant hantavirus nucleocapsid protein expressed in silkworm larvae and its use as a diagnostic antigen in detecting antibodies in serum from infected rats.
Lab. Anim. Sci.
45:641-646[Medline].
|
Journal of Clinical Microbiology, September 1998, p. 2514-2521, Vol. 36, No. 9
0095-1137/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Okumura, M., Yoshimatsu, K., Kumperasart, S., Nakamura, I., Ogino, M., Taruishi, M., Sungdee, A., Pattamadilok, S., Ibrahim, I. N., Erlina, S., Agui, T., Yanagihara, R., Arikawa, J.
(2007). Development of Serological Assays for Thottapalayam Virus, an Insectivore-Borne Hantavirus. CVI
14: 173-181
[Abstract]
[Full Text]
-
Meisel, H., Wolbert, A., Razanskiene, A., Marg, A., Kazaks, A., Sasnauskas, K., Pauli, G., Ulrich, R., Kruger, D. H.
(2006). Development of Novel Immunoglobulin G (IgG), IgA, and IgM Enzyme Immunoassays Based on Recombinant Puumala and Dobrava Hantavirus Nucleocapsid Proteins. CVI
13: 1349-1357
[Abstract]
[Full Text]
-
Yoshimatsu, K., Lee, B.-H., Araki, K., Morimatsu, M., Ogino, M., Ebihara, H., Arikawa, J.
(2002). The Multimerization of Hantavirus Nucleocapsid Protein Depends on Type-Specific Epitopes. J. Virol.
77: 943-952
[Abstract]
[Full Text]
-
Araki, K., Yoshimatsu, K., Ogino, M., Ebihara, H., Lundkvist, A., Kariwa, H., Takashima, I., Arikawa, J.
(2001). Truncated Hantavirus Nucleocapsid Proteins for Serotyping Hantaan, Seoul, and Dobrava Hantavirus Infections. J. Clin. Microbiol.
39: 2397-2404
[Abstract]
[Full Text]